Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Buser

Showing results (61-70 of 104) with videos related to

Pageof 11
Sort By:
British Journal of Haematology|September 16, 2009
In vitro anti-myeloma activity of the Aurora kinase inhibitor VE-465Joseph M Negri, Douglas W McMillin, Jake Delmore, et al.
BMC Medical Genomics|January 22, 2011
EMT is the dominant program in human colon cancerAndre Loboda, Michael V Nebozhyn, James W Watters, et al.
Archives of Biochemistry and Biophysics|November 15, 2007
Discovery and biochemical characterization of selective ATP competitive inhibitors of the human mitotic kinesin KSPKeith W Rickert, Michael Schaber, Maricel Torrent, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2005
Kinesin spindle protein (KSP) inhibitors. Part 1: The discovery of 3,5-diaryl-4,5-dihydropyrazoles as potent and selective inhibitors of the mitotic kinesin KSPChristopher D Cox, Michael J Breslin, Brenda J Mariano, et al.
Infection|July 18, 2012
Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantationA Egli, C Bucher, A Dumoulin, et al.
Biofactors (Oxford, England)|January 1, 1997
Farnesyl: proteintransferase inhibitors as agents to inhibit tumor growthC A Omer, N J Anthony, C A Buser-Doepner, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2003
Optimization of the indolyl quinolinone class of KDR (VEGFR-2) kinase inhibitors: effects of 5-amido- and 5-sulphonamido-indolyl groups on pharmacokinetics and hERG bindingMark E Fraley, Kenneth L Arrington, Carolyn A Buser, et al.
Vox Sanguinis|January 15, 2010
Transfusion policy in ABO-incompatible allogeneic stem cell transplantationN Worel, S Panzer, H W Reesink, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2001
Aryloxy substituted N-arylpiperazinones as dual inhibitors of farnesyltransferase and geranylgeranyltransferase-IJ M Bergman, M T Abrams, J P Davide, et al.
The Journal of Biological Chemistry|March 29, 2001
Anions modulate the potency of geranylgeranyl-protein transferase I inhibitorsH E Huber, R G Robinson, A Watkins, et al.
Pageof 11

Showing results (61-70 of 104) with videos related to

Sort By:
Pageof 11
British Journal of Haematology|September 16, 2009
In vitro anti-myeloma activity of the Aurora kinase inhibitor VE-465Joseph M Negri, Douglas W McMillin, Jake Delmore, et al.
BMC Medical Genomics|January 22, 2011
EMT is the dominant program in human colon cancerAndre Loboda, Michael V Nebozhyn, James W Watters, et al.
Archives of Biochemistry and Biophysics|November 15, 2007
Discovery and biochemical characterization of selective ATP competitive inhibitors of the human mitotic kinesin KSPKeith W Rickert, Michael Schaber, Maricel Torrent, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2005
Kinesin spindle protein (KSP) inhibitors. Part 1: The discovery of 3,5-diaryl-4,5-dihydropyrazoles as potent and selective inhibitors of the mitotic kinesin KSPChristopher D Cox, Michael J Breslin, Brenda J Mariano, et al.
Infection|July 18, 2012
Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantationA Egli, C Bucher, A Dumoulin, et al.
Biofactors (Oxford, England)|January 1, 1997
Farnesyl: proteintransferase inhibitors as agents to inhibit tumor growthC A Omer, N J Anthony, C A Buser-Doepner, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2003
Optimization of the indolyl quinolinone class of KDR (VEGFR-2) kinase inhibitors: effects of 5-amido- and 5-sulphonamido-indolyl groups on pharmacokinetics and hERG bindingMark E Fraley, Kenneth L Arrington, Carolyn A Buser, et al.
Vox Sanguinis|January 15, 2010
Transfusion policy in ABO-incompatible allogeneic stem cell transplantationN Worel, S Panzer, H W Reesink, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2001
Aryloxy substituted N-arylpiperazinones as dual inhibitors of farnesyltransferase and geranylgeranyltransferase-IJ M Bergman, M T Abrams, J P Davide, et al.
The Journal of Biological Chemistry|March 29, 2001
Anions modulate the potency of geranylgeranyl-protein transferase I inhibitorsH E Huber, R G Robinson, A Watkins, et al.
Pageof 11